β-amyloid monomer scavenging by an anticalin protein prevents neuronal hyperactivity in mouse models of Alzheimer’s Disease

Overview of attention for article published in Nature Communications, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 16 news outlets
blogs: 3 blogs

twitter: 19 X users
facebook: 1 Facebook page

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 18 news stories from 16 outlets.

New treatment targeting biological molecule that drives Alzheimer's disease progression shows promising results in animal studies

Gigazine, 27 Sep 2024

A research team from the Technical University of Munich has announced that it has succeeded in developing a new treatment that…

アルツハイマー病の進行を引き起こす生体分子を標的とした新治療法が動物実験で有望な結果を出す

Gigazine, 27 Sep 2024

ミュンヘン工科大学の研究チームが、アルツハイマー病を進行させる生体分子「アミロイドβ」を標的とした新たな治療法の開発に成功し、マウスでの動物実験で有望な結果が示されたことを発表しました。 β-amyloid monomer scavenging by…

New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials

PressNewsAgency, 25 Sep 2024

A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have…

Amyloid-β Monomer Clearance with Anticalins

Fight Aging!, 28 Aug 2024

August 28th, 2024 Researchers here argue that the fine details of how and when amyloid-β is cleared from the brain matters…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 14 additional news stories.